A Unique GSK-3β inhibitor B10 Has a Direct Effect on Aβ, Targets Tau and Metal Dyshomeostasis, and Promotes Neuronal Neurite Outgrowth
Due to the complicated pathogenesis of Alzheimer’s disease (AD), the development of multitargeted agents to simultaneously interfere with multiple pathological processes of AD is a potential choice. Glycogen synthase kinase-3β (GSK-3β) plays a vital role in the AD patholo...
Main Authors: | Xiao-Long Shi, Ning Yan, Ying-Jie Cui, Zhao-Peng Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/3/649 |
Similar Items
-
Effects of siRNA-Mediated Knockdown of GSK3β on Retinal Ganglion Cell Survival and Neurite/Axon Growth
by: Zubair Ahmed, et al.
Published: (2019-08-01) -
The functionalized amino acid (S)-Lacosamide subverts CRMP2-mediated tubulin polymerization to prevent constitutive and activity-dependent increase in neurite outgrowth
by: Sarah M Wilson, et al.
Published: (2014-07-01) -
Modification of the Drosophila model of in vivo Tau toxicity reveals protective phosphorylation by GSK3β
by: Giulia Povellato, et al.
Published: (2013-11-01) -
Morin attenuates tau hyperphosphorylation by inhibiting GSK3β
by: Eun Ji Gong, et al.
Published: (2011-11-01) -
GSK3β and Tau Protein in Alzheimer’s Disease and Epilepsy
by: Danira Toral-Rios, et al.
Published: (2020-03-01)